N/A N=279 Tension Versus Tension- Free Foley Balloon for Cervical Ripening
Induced Vaginal Delivery
Primary: Time to Vaginal Delivery — 1608; 1595.5 minutes
Clinical Trial Search
Completed trials with posted results — search by concept, filter by the parameters that matter at the bedside.
Phase 2 N=10 A Prospective Study to Assess the Hypotensive Efficacy of Rho-Kinase Inhibitor AR-12286 Ophthalmic Solution 0.5% and 0.7% in Patients With Exfoliation Syndrome and Ocular Hypertension or Glaucoma
Exfoliation Syndrome · Ocular Hypertension · Open Angle Glaucoma
Primary: Evaluate the Ocular Hypotensive Efficacy of Rho Kinase Inhibitor (AR-12286 0.5% and 0.7%) — 24.2; 25.8 mmHg
N/A N=36 Tension of THERABAND® Kinesiology Tape on Shoulder Pain
Shoulder Pain
Primary: Numeric Pain Rating Scale (NPRS) — 5.458; 5.115; 4.708; 3.808 units on a scale
Phase 4 N=59 Use of Bevacizumab in Trabeculectomy Surgery
Glaucoma · Optic Neuropathy · Fibrosis
Primary: Intraocular Pressure — 13.9; 13.2 mm Hg — p=<0.05
N/A N=16 Effect of Travoprost 0.004% on Retinal Oximetry in Primary Open Angle Glaucoma
Primary Open Angle Glaucoma
Primary: Blood Oxygenation — 60; 60; 60 percentage of oxygenation
Phase 4 N=123 Metoclopramide Versus Ketorolac for Tension-type Headache
Headache
Primary: Change in Pain Score — 3.8; 5.1 units on a scale
N/A N=144 Balloon Catheter for Cervical Ripening
Cervical Dilation
Primary: Duration — 16.2; 16.9 hours — p=0.814
Phase 4 N=52 Earlier Intraocular Pressure Control After Ahmed Glaucoma Valve Implantation for Glaucoma
Glaucoma
Primary: Rate of Hypertensive Phase After Ahmed Valve Implantation for Glaucoma — 9; 12 participants
N/A N=235 The Support, Educate, Empower (SEE) Program
Glaucoma
Primary: Mean Percent Electronically Monitored Medication Adherence Over Six Months — 77.6; 58.0 percent adherence — p=<0.001
N/A N=44 Intraocular Pressure and Ocular Perfusion Pressure of Cosopt in Normal Tension Glaucoma
Normal Tension Glaucoma
Primary: Intraocular Pressure (IOP), Period 1 — 13.72; 13.50; 13.27; 13.36 mmHg — p=0.05
Phase 4 N=32 Investigation of Intraocular Pressure (IOP) Reduction Efficacy of Travoprost Ophthalmic Solution in Patients With Normal Tension Glaucoma
Normal Tension Glaucoma · Ocular Hypertension
Primary: Mean Change From Baseline in IOP (9:00 AM) at Week 4, Week 8, and Week 12 — 16.55; -3.37 mmHg
N/A N=902 Observational Study of the Long-term Effect of Latanoprost in Normal Tension Glaucoma
Low Tension Glaucoma
Primary: Change From Baseline in Raw Intraocular Pressure (IOP) by Visit — -3.20; -3.12; -3.22; -3.43 mmHg
Phase 4 N=1 Additive Effect of Twice-daily Brinzolamide 1%/Brimonidine 0.2%Combination as an Adjunctive Therapy to Travoprost in Patients With Normal Tension Glaucoma
Glaucoma
Primary: Mean Change From Baseline in Diurnal IOP at Week 6
N/A N=49 Systemic Glutathione Level in Normal Tension Glaucoma
Normal Tension Glaucoma
Primary: Total Glutathione Levels — 524.02; 586.06 nmol
N/A N=20 Virtual Reality for Improving Pain and Distress in Patients With Advanced Stage Colorectal Cancer
Colorectal Cancer
Primary: Feasibility, Assessed by Examining Number of Participants Accrued — 20 Participants